Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for alopecia show no significant long-term benefits.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Minoxidil effectively treats female pattern hair loss.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Some botanical products may help increase hair growth in people with alopecia, but more research is needed.

The document concludes that there is a need for more research and regulation in dermatology, covering topics like latex allergy in children, the use of botulinum toxin, and treatments for skin conditions.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

New understanding of hair loss could lead to better treatments.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Lasers and light therapies are effective in promoting hair regrowth for different types of hair loss.

Both microneedling and injections are equally effective for treating alopecia areata.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

The treatment with valproate, acetylcarnitine, folic acid, and vitamin B12 may improve muscle strength in children with SMA without significant side effects.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.